MAPT and Alzheimer disease: Quite recently, it has been tested whether a preclinical AD pathologic feature, tau aggregation in the EC, can disrupt the coordination of LFPs between its two efferent regions, the hippocampus and prelimbic mPFC (Figure 4; Tanninen et al., 2017).